Introduction of soluble protein into the class I pathway of antigen processing and presentation.
about
P1343
Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation siteDisruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell functionTwo putative subunits of a peptide pump encoded in the human major histocompatibility complex class II regionRegulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunityImmune tolerance after delivery of dying cells to dendritic cells in situSerum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I moleculesENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsTherapeutic limitations in tumor-specific CD8+ memory T cell engraftmentGamma-herpesvirus latency requires T cell evasion during episome maintenanceCross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsUsing magnetic resonance imaging to evaluate dendritic cell-based vaccinationUse of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionThe transporter associated with antigen processing: function and implications in human diseasesMacrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activationIn vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigensDiscs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+ T Cells.Pillars article: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263.An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsRecognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.Enhancing CD8 T-cell memory by modulating fatty acid metabolismHeat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes.CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissuesSalmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice.Stimulation of protective CD8+ T lymphocytes by vaccination with nonliving bacteria.A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice.Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation.Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigenThe use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo.Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells.Processing of Listeria monocytogenes antigens and the in vivo T-cell response to bacterial infection.Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptidesPreexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectorsLimited transplantation of antigen-expressing hematopoietic stem cells induces long-lasting cytotoxic T cell responsesMajor histocompatibility complex class I-restricted activation of cloned T cells by a soluble protein in the absence of accessory cells
P2860
Q24321802-462C10C4-3ED5-4E3F-9839-51F67BF85E1BQ24558690-DF28959C-41D2-41E4-A88F-64C662B8C58EQ24560017-5D952BA2-6505-4432-8BE6-21F247EA9B8EQ24610550-80B0484A-15AF-4C76-99E9-A6504973BDE6Q24673068-8A4E540B-697E-448A-B1DC-499A5243A508Q24675294-A11667DC-77CE-4FA9-8650-AAD7E6524181Q24682788-28A07FFB-A490-4A5E-A548-D697CC0C6D53Q24794258-CBBA371C-F2CB-48FA-8581-BC82F57060E7Q24803420-753FD6D0-6168-41B1-BBD7-F744D054C47CQ26799991-D9FC82DB-7DAF-45E6-B5BC-8AECC6777055Q27316977-14BB727A-8520-4D8D-9601-A8DD5DCBF493Q27480326-C3FCC188-5E05-486D-B712-EC25D52C0711Q28214433-4E215D13-A75D-4008-BE18-45EFC5FA3C4DQ28366007-A79D6110-AFEB-4BAB-AE17-5647E86A85EBQ29615098-FC36850E-B72F-4763-9FCD-5A662BBAFDE6Q30009140-8884F91C-DB21-45CD-BDD8-E0FD957A5A69Q30370319-7E4E0A91-4B9F-4B46-951A-8B9B6484BC4CQ30442847-EE2C20D2-8FDF-41EA-B485-9BBA39F78863Q30442874-B7265D15-BD32-45C8-AD06-EDE06E19E6B1Q30466290-3D715AB1-4EED-4989-981B-FB639D6D9D24Q30481516-127F98D5-0362-491A-A49F-AA09091BAAF2Q30990189-9CB8E2A6-5318-4D88-A988-2B45BDDF3210Q31775839-A6C53AC4-1044-4906-AAAA-1A9AA5B073F3Q33577204-896DCC7B-4D6F-490A-99A5-4BDB219C98AAQ33585305-C2E64D5B-3B49-4C04-A9B5-12CEF760C45CQ33591737-75E93CC5-7F3F-48C2-B734-90FB6C91BD34Q33615216-32F9CA81-3F83-405E-A482-58671ED8FBFAQ33617904-B6E88F88-361B-4D90-91A1-A1BB144C802DQ33676452-3A41E383-8BE7-4F10-ACBC-C4B110EB1EC1Q33724878-D9676A90-C1F5-4298-A8AE-FB78B712997BQ33730763-52842A23-C016-4087-808E-5C3056162651Q33752783-C08355D4-ABB7-4A77-822A-782BBD0E3A34Q33755289-5EB2726D-6F78-4227-8D9B-4518E7F98478Q33778844-290D64F4-BA8A-4B60-8A42-2753BE67C9F9Q33793700-16519DE2-A24F-467B-9B9B-4AFBCBD8A736Q33815413-D8F49C8D-8981-4B4F-9572-5C377A270A03Q33816489-56DDD398-1697-474B-B4CE-300275DD4839Q33835258-8236187B-2F89-42D2-90E7-3675B1C599CCQ33838390-0A9E0859-8BB6-4A9A-B460-E5DF9AD4273AQ33847315-5C5672B7-2F19-4662-9F2F-B6D025822DC2
P2860
Introduction of soluble protein into the class I pathway of antigen processing and presentation.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Introduction of soluble protei ...... n processing and presentation.
@en
Introduction of soluble protei ...... n processing and presentation.
@nl
type
label
Introduction of soluble protei ...... n processing and presentation.
@en
Introduction of soluble protei ...... n processing and presentation.
@nl
prefLabel
Introduction of soluble protei ...... n processing and presentation.
@en
Introduction of soluble protei ...... n processing and presentation.
@nl
P2093
P1433
P1476
Introduction of soluble protei ...... n processing and presentation.
@en
P2093
P304
P356
10.1016/S0092-8674(88)91043-4
P407
P4510
P577
1988-09-01T00:00:00Z